ArticleBioinformatics advances2026
Interpretable prediction of nucleic acid-binding proteins using a protein language model.
Article in Bioinformatics advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Motivation: Accurate identification of DNA-binding proteins (DBPs) and RNA-binding proteins (RBPs) is critical for elucidating transcriptional and post-transcriptional regulatory mechanisms. However, existing computational approaches often rely on inferred labels or domain-specific annotations, which limit the subsequent generalizability. Results: This study aimed to introduce transformer-based classifiers for human DBPs and RBPs that rely solely on protein sequence information without engineered features or domain constraints. The models were implemented using ESM-2 with low-rank adaptation (LoRA) fine-tuning and trained on experimentally validated datasets, including chromatin immunoprecipitation sequencing (ChIP-seq) annotations for DBPs and eCLIP annotations for RBPs. Next, to evaluate biological relevance, we computed value-aware attention (VAT) scores aggregated across transformer layers to interpret model focus. In 20-fold cross-validation, the DBP model achieved an area under the receiver operating characteristic curve (AUROC) of 0.84 with a Matthews correlation coefficient (MCC) of 0.40, while the RBP model achieved an AUROC of 0.92 with an MCC of 0.46. Proteins predicted as nucleic acid-binding were enriched for known binding domains, and inspection of attention distributions revealed preferential focus on annotated functional regions rather than non-binding segments. These results demonstrate that attention-based protein language models can accurately identify nucleic acid-binding proteins directly from sequence data. Moreover, these models reveal biologically meaningful sequence determinants of binding, establishing an interpretable and scalable framework for proteome-wide characterization of protein-nucleic acid interactions. Availability and implementation: Code is available on GitHub (https://github.com/CSB-hub/DRBP).
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.